This study investigates the effects of an investigational medication compared to a placebo in adults with high-risk asthma. The purpose is to evaluate the safety and effectiveness of this add-on therapy in participants who are not eligible for biologic treatments. Participants will be involved in the study for about 64 …
This study investigates the effectiveness of adding an investigational medication to the treatment regimen of patients with uncontrolled asthma. Uncontrolled asthma refers to patients who continue to experience frequent symptoms despite their current medication. The study compares two treatment arms: one where participants receive the investigational medication along with their …
This study investigates the long-term safety and efficacy of an investigational medication in adults with asthma. It is an extension of previous studies and will last up to 100 weeks, with participants receiving treatment for up to 96 weeks. The purpose of this study is to continue monitoring the effects …
The purpose of this study is to investigate the long-term effects of an investigational medication on preventing lung function decline in adults with uncontrolled moderate to severe asthma. The study will last for a total of 3 years, following a screening and run-in period of about 4 weeks. Participants will …
This study investigates the effects and safety of an investigational medication in children aged 2 to less than 6 years who have uncontrolled asthma or severe asthmatic wheeze. The purpose is to understand how well the medication works and how safe it is for long-term use in this age group. …
